empanelment of drug testing laboratories - Kerala Medical Services ...

More documents

Recommendations

Info

ANNUAL TURN OVER STATEMENT ANNEXURE- V Ref. Clause No.5.10.16 The annual Turnover of M/s………………………… …………………… for the past three years are given below and certified that the statement is true and correct. Sl.no: year Turnover 1 2009-2010 2 2010-2011 3 2011-2012 Total Rs …………..lakhs Average annual turnover - Rs…………….Lakhs Date: Signature of auditor/ Chartered Accountant (Name in capital) Seal: KMSCL: EOI for Empanelment of Drug testing Laboratories Page 43
DECLARATION FORM ANNEXURE-VI Ref. Clause No.5.10.17 I / We ………………………………………………………………… (Name of the laboratory) having our office at ……………………………………………………………………………………………… ……………………………………………………………………………………… Lab at ……………………………………………………………………………………………… …..………………………………….. do declare that I / We have carefully read all the conditions of EOI document of Kerala Medical Services Corporation Ltd., Thiruvananthapuram, for the EOI floated for empanelment of analytical testing laboratories for the analysis of drugs / surgical / sutures etc., for a period of two years from the date of acceptance and abide by all conditions set forth therein. I / We further declare that I / We posses valid License bearing No. ………………………………………………………………………………. valid upto. ……………………………………….. Signature : Date : Name of the Lab : Office Seal : ATTESTED BY NOTARY PUBLIC KMSCL: EOI for Empanelment of Drug testing Laboratories Page 44
Page 1 and 2: KERALA MEDICAL SERVICES CORPORATION
Page 3 and 4: SECTION I INTRODUCTION 1.1. The Ker
Page 5 and 6: SECTION - II INVITATION OF EXPRESSI
Page 7 and 8: 2.16. The EOI Responder must submit
Page 9 and 10: 4.1 Time Limits Prescribed: SECTION
Page 11 and 12: 5.1 Contents of the EOI Document: S
Page 13 and 14: 5.4.10 A prospective offerer requir
Page 15 and 16: 5.7.4 It is also an opportunity for
Page 17 and 18: 5.10.17 Declaration in the Proforma
Page 19 and 20: opening of the envelopes before the
Page 21 and 22: 5.17.7 The availability of technica
Page 23 and 24: 5.22 Notification of Award/Letter o
Page 25 and 26: 5.24.6 Corporation will release the
Page 27 and 28: egard shall be in writing and the C
Page 29 and 30: testing fees at artificial non-comp
Page 31 and 32: 5.33.1 Nothing contained in this Co
Page 33 and 34: ANNEXURES KMSCL: EOI for Empanelmen
Page 35 and 36: EOI Cost EMD 12. Annexure VII - Det
Page 37 and 38: No.4.2.8 (Provide contact details l
Page 39 and 40: ANNEXURE- II (b) Ref. Clause No.5.1
Page 41 and 42: ANNEXURE-III Ref. Clause No.5.10.3
Page 43: PROFORMA FOR PERFORMANCE STATEMENT
Page 47 and 48: CONSENT LETTER OF THE OFFERER From,
Page 49 and 50: liability under this guarantee and
Page 51 and 52: And whereas the Laboratory has depo
Page 53 and 54: which bank details shall be furnish
Page 55 and 56: 14. In the event of any disputes be
Page 57 and 58: 39 D04017 Bupivacaine In Dextrose I
Page 59 and 60: 101 D18007/ Electrolyte P(Multi Inj
Page 61 and 62: 160 D02025 Metronidazole IP. Inj 5
Page 63 and 64: 228 D03001 Theophylline and Etophyl
Page 65 and 66: 40 S27050 Endotracheal Tube 5.0 1 U
Page 67 and 68: 19 S27004 Hypo Allergic Acrylic Pap
Page 69 and 70: 25 S27572 26 S27531 27 S27574 28 S2
Page 71 and 72: DETAILS OF LABRATES FOR THE DRUGS A
Page 73 and 74: 45 D11006 Cabergoline tab Tab 0.5mg
Page 75 and 76: 88 D01028 Diclofenac sodium Gel Gel
Page 77 and 78: 126 D02074 Hpylori kit Each combi p
Page 79 and 80: 163 D04026 Lignocaine topical Spray
Page 81 and 82: 207 D24052 Octreotide Inj Inj 50 mc
Page 83 and 84: 255 D08028 Pyrantel Palmoate Syrup
Page 85: 302 D20037 Ursodeoxycholic Acid Tab

empanelment of drug testing laboratories - Kerala Medical Services ...

Create successful ePaper yourself

Delete template?

Save as template?